Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Increasing GPT activity for colorectal cancer

February 26, 2025 11:39 PM UTC

Increasing activity of the metabolic enzyme GPT could help treat colorectal cancer by promoting colon production of the Krebs cycle metabolite α-ketoglutarate, which reduces tumorigenic WNT signaling, while also directly binding and promoting the degradation of the carcinogenic folate cycle enzyme MTHFD1L.

A transcriptomic analysis of paired normal mucosa, advanced adenoma, and carcinoma tissues from six patients with colorectal cancer and adenomas, followed by validation in paired tissues from 30 patients, identified GTP as downregulated throughout disease progression, with GPT mRNA and protein expression being lower in advanced adenoma samples than in adjacent normal mucosa samples, and even lower in carcinoma samples. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Sun Yat-sen University